146 related articles for article (PubMed ID: 33197301)
1. Constitutive low expression of antiviral effectors sensitizes melanoma cells to a novel oncolytic virus.
Dellac S; Ben-Dov H; Raanan A; Saleem H; Zamostiano R; Semyatich R; Lavi S; Witz IP; Bacharach E; Ehrlich M
Int J Cancer; 2021 May; 148(9):2321-2334. PubMed ID: 33197301
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and Interferon-α Signaling
Danziger O; Pupko T; Bacharach E; Ehrlich M
Front Immunol; 2018; 9():94. PubMed ID: 29441069
[TBL] [Abstract][Full Text] [Related]
3. Lipocalin-2 regulates the expression of interferon-stimulated genes and the susceptibility of prostate cancer cells to oncolytic virus infection.
Barer L; Schröder SK; Weiskirchen R; Bacharach E; Ehrlich M
Eur J Cell Biol; 2023 Jun; 102(2):151328. PubMed ID: 37321037
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus.
Allagui F; Achard C; Panterne C; Combredet C; Labarrière N; Dréno B; Elgaaied AB; Pouliquen D; Tangy F; Fonteneau JF; Grégoire M; Boisgerault N
Curr Gene Ther; 2017; 16(6):419-428. PubMed ID: 28042780
[TBL] [Abstract][Full Text] [Related]
5. Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection.
Danziger O; Shai B; Sabo Y; Bacharach E; Ehrlich M
Oncotarget; 2016 Aug; 7(32):52115-52134. PubMed ID: 27366948
[TBL] [Abstract][Full Text] [Related]
6. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
[TBL] [Abstract][Full Text] [Related]
7. PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.
Sobol PT; Hummel JL; Rodrigues RM; Mossman KL
Gene Ther; 2009 Sep; 16(9):1077-87. PubMed ID: 19474810
[TBL] [Abstract][Full Text] [Related]
8. Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.
Yu N; Puckett S; Antinozzi PA; Cramer SD; Lyles DS
J Virol; 2015 May; 89(10):5250-63. PubMed ID: 25741004
[TBL] [Abstract][Full Text] [Related]
9. Naturally Occurring and Engineered Alphaviruses Sensitive to Double-Stranded-RNA-Activated Protein Kinase Show Restricted Translation in Mammalian Cells, Increased Sensitivity to Interferon, and Marked Oncotropism.
Toribio R; Díaz-López I; Berlanga JJ; Molina-Jiménez F; Majano P; Ventoso I
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723025
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity.
Ying L; Cheng H; Xiong XW; Yuan L; Peng ZH; Wen ZW; Ka LJ; Xiao X; Jing C; Qian TY; Liang GZ; Mei YG; Bo ZW; Liang P
Oncotarget; 2017 Apr; 8(15):24694-24705. PubMed ID: 28445966
[TBL] [Abstract][Full Text] [Related]
12. Tanapoxvirus lacking the 15L gene inhibits melanoma cell growth in vitro by inducing interferon-λ1 release.
Zhang T; Essani K
Virus Genes; 2017 Jun; 53(3):477-482. PubMed ID: 28188458
[TBL] [Abstract][Full Text] [Related]
13. Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses.
Matveeva OV; Chumakov PM
Rev Med Virol; 2018 Nov; 28(6):e2008. PubMed ID: 30209859
[TBL] [Abstract][Full Text] [Related]
14. Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model.
Ruotsalainen JJ; Kaikkonen MU; Niittykoski M; Martikainen MW; Lemay CG; Cox J; De Silva NS; Kus A; Falls TJ; Diallo JS; Le Boeuf F; Bell JC; Ylä-Herttuala S; Hinkkanen AE; Vähä-Koskela MJ
Gene Ther; 2015 Jan; 22(1):65-75. PubMed ID: 25231172
[TBL] [Abstract][Full Text] [Related]
15. Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling.
Malilas W; Koh SS; Srisuttee R; Boonying W; Cho IR; Jeong CS; Johnston RN; Chung YH
Cancer Gene Ther; 2013 Feb; 20(2):125-32. PubMed ID: 23306614
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Interferon Regulatory Factor 7 in Nicotine's Suppression of Antiviral Immune Responses.
Han H; Huang W; Du W; Shen Q; Yang Z; Li MD; Chang SL
J Neuroimmune Pharmacol; 2019 Dec; 14(4):551-564. PubMed ID: 31154625
[TBL] [Abstract][Full Text] [Related]
17. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
18. Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription.
Cheng J; Zhao Q; Zhou Y; Tang L; Sheraz M; Chang J; Guo JT
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581092
[TBL] [Abstract][Full Text] [Related]
19. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of innate immune signaling pathways in transformed cells.
Heiber JF; Barber GN
Methods Mol Biol; 2012; 797():217-38. PubMed ID: 21948479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
